Past Press

BARDA funds development of rapid sepsis test, digital diagnostic tool
October 31, 2019

The Biomedical Advanced Research and Development Authority (BARDA) announced that it will provide Cytovale of San Francisco an initial $3.4 million, with an option for an additional $4.17 million, to ...

Read More
Sepsis diagnostics: HHS to advance development of Cytovale rapid test
October 30, 2019

To advance the development of a test that may be able to diagnose sepsis in less than 10 minutes, the U.S. Department of Health and Human Services (HHS) will partner with Cytovale of San Francisco....

Read More
Medtech business Cytovale raised $7.4 million in an extension of its Series B
October 30, 2019

The funding is intended to support advancement of its tool for early detection of sepsis in the emergency department....

Read More
Cytovale Raises $15M in Funding
October 30, 2019

Cytovale, Inc., a San Francisco, Calif.-based medical technology company dedicated to innovating diagnostics using cell mechanics and machine learning, raised $15m in financing....

Read More
Cytovale Bags $15M for Sepsis-Detecting Tech
October 30, 2019

Cytovale today announced a $15 million financing for its sepsis-detecting technology for use in the emergency department....

Read More
Cytovale Receives $15M to Advance Sepsis Detection Tech
October 30, 2019

Cytovale announced today it has received a total of $15 million in financing to advance its technology for the early detection of sepsis in the emergency department....

Read More

Contact Us